查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1880712

2034年全球生物工程技術市場機會與策略

Bioengineering Technology Global Market Opportunities And Strategies To 2034
出版日期: | 出版商: The Business Research Company | 英文 397 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

全球生物工程技術市場預計到2024年將達到約3,203.8084億美元，自2019年以來年複合成長率（CAGR）為13.45%。預計該市場將從2024年的3,203.8084億美元成長到2029年的5,651.6447億美元，年複合成長率為12.02%。此後，預計從2029年起將以10.26%的年複合成長率成長，到2034年達到9,208.388億美元。

生物工程技術是將工程原理和技術應用於生物系統和生物體，旨在為醫療保健、農業和工業開發創新產品、製程和解決方案。它整合了生物技術、材料科學、電子學和計算建模等領域，以應對醫學、遺傳學、環境永續性和生物製造方面的挑戰。生物工程技術的主要目標是改善人類健康、提高生活品質並促進永續性。

人們對細胞療法的興趣日益濃厚

過去一段時間，人們對細胞療法的日益關注推動了生物工程技術市場的成長。由於細胞療法需要先進的細胞培養、基因工程和生物製程工具，因此，對該領域日益成長的興趣正在推動生物工程技術市場的發展。再生醫學和個人化醫療領域不斷成長的投資進一步促進了生物工程解決方案的創新和廣泛應用。例如，根據美國基因與細胞治療學會（ASGCT）2024年4月發布的數據，第四季（Q4）處於III期臨床試驗階段的基因療法數量增加了10%，這是自2022年第三季（Q3）以來的首次以季度為基礎成長。因此，可以說，人們對細胞療法的日益關注推動了生物工程技術市場的成長。

自動化組織解離系統提高了細胞治療和研究的效率

生物工程技術市場的主要企業正致力於提高細胞活力和細胞產量，以簡化基於細胞的療法和生物製造流程。這些創新旨在降低生產成本、增強擴充性並加速先進治療方法的開發。例如，2025年6月，總部位於加拿大的生物技術公司STEMCELL Technologies推出了STEMprep組織分散系統，這是一款桌上型設備，可自動且標準化組織分散過程，將固態組織轉化為高品質的單細胞懸浮液。 STEMprep旨在縮短時間並提高一致性，同時保持細胞的完整性和功能，從而支持精確的分離和分析。研究人員可以利用檢驗的通訊協定或針對不同組織類型客製化工作流程，從而提高效率、可重複性和數據可靠性，最終加速腫瘤學和免疫學等領域的研究。

全球生物工程技術市場較為分散，由眾多小規模的企業組成。到2024年，市場前十大競爭對手將佔據11.55%的市場。

目錄

第1章執行摘要

  • 生物工程技術－市場吸引力與宏觀經濟環境

第2章 目錄

第3章表格一覽

第4章圖表一覽

第5章 報告結構

第6章 市場特徵

  • 一般市場定義
  • 概述
  • 生物工程技術市場定義與細分
  • 按產品分類的市場細分
    • 生物醫學工程
    • 基因工程
    • 組織工程
    • 生物材料
    • 生物力學工程
    • 奈米生物技術
    • 其他產品
  • 市場區隔：依技術分類
    • 奈米生物技術
    • 組織工程與再生醫學
    • DNA定序
    • 基於細胞的檢測
    • 發酵
    • 層析法
    • PCR技術
    • 其他技術
  • 市場區隔：按應用
    • 衛生保健
    • 食品和農業
    • 自然資源/環境
    • 工業製程領域
    • 生物資訊學
    • 其他應用領域

第7章：主要市場趨勢

  • 自動化組織解離系統提高了細胞治療和研究效率
  • 新一代水稻種植技術兼具效率與韌性
  • 基於模擬的工具在醫療設備監管領域日益受到重視
  • 先進、耐用的PTMEG專為高性能應用而設計
  • 尖端義肢技術兼顧了價格和性能。
  • 突破性儀器為生物奈米顆粒分析帶來一致性
  • 人工智慧驅動的組體學整合為生物醫學創新樹立了新標準
  • 人工智慧驅動的RNA定序與分析革新了精準醫學研究
  • 新一代基因組分析技術借助液態生物檢體創新，革新精準腫瘤學。
  • 超高速NGS技術革新了體細胞癌分析。
  • 新一代平台利用光學和電學組織分析增強臨床前藥物測試。

第8章 生物工程技術成長分析與策略分析框架

  • 全球生物工程技術PESTEL分析（政治、社會、技術、環境與法律因素）
    • 政治的
    • 經濟
    • 社會的
    • 技術的
    • 環境
    • 法律事務
  • 最終用戶分析（B2B）
    • 醫院
    • 研究和學術機構
    • 製藥和生物技術公司
    • 診斷檢查室
    • 醫療設備製造商
    • 其他最終用戶（合約研究機構 (CRO)、政府和監管機構、農業和食品加工公司）
  • 生物工程技術市場：成長率分析
  • 2019-2024年全球市場成長表現
    • 2019-2024年市場促進因素
    • 2019-2024年市場限制
  • 全球市場成長預測，2024-2029年，2034年預測
  • 預計成長要素/貢獻者
    • 定量成長要素
    • 促進要素
    • 抑制因素
  • 生物工程技術：總潛在市場規模 (TAM)

9. 生物工程技術市場：細分

  • 全球生物工程技術市場：依產品、性能及預測分類，2019-2024年、2029年預測、2034年預測
  • 全球生物工程技術市場：依技術、性能及預測分類，2019-2024年、2029年預測、2034年預測
  • 全球生物工程技術市場：依應用、效能和預測分類，2019-2024年、2029年預測、2034年預測
  • 全球生物工程技術市場：按生物醫學工程、類型、性能和預測進行細分，2019-2024年、2029年預測、2034年預測
  • 全球生物工程技術市場：按基因工程、類型、性能和預測細分，2019-2024年、2029年預測、2034年預測
  • 全球生物工程技術市場：依組織工程、類型、性能及預測細分，2019-2024年、2029年預測、2034年預測
  • 全球生物工程技術市場：依生物材料、類型、性能和預測細分，2019-2024年、2029年預測、2034年預測
  • 全球生物工程技術市場：依生物力學工程、類型細分，實際值及預測值（2019-2024年、2029年預測值、2034年預測值）
  • 全球生物工程技術市場：按奈米生物技術、類型、性能和預測進行細分（2019-2024年、2029年預測、2034年預測）。
  • 全球生物工程技術市場：依產品、類型細分，實際值及預測值（2019-2024年、2029年預測值、2034年預測值）

第10章 生物工程技術市場：區域與國家分析

  • 生物工程技術市場：區域表現及預測，2019-2024年、2029年預測、2034年預測
  • 生物工程技術市場：國家、績效及預測，2019-2024年、2029年預測、2034年預測

第11章 亞太市場

第12章 西歐市場

第13章 東歐市場

第14章 北美市場

第15章：南美市場

第16章 中東市場

第17章：非洲市場

第18章：競爭格局與公司概況

  • 公司簡介
  • Thermo Fisher Scientific Inc
  • Roche Holding AG
  • Pfizer Inc
  • Illumina Inc
  • Agilent Technologies Inc

第19章：其他領先和創新企業

  • AstraZeneca plc
  • Lonza Group Ltd.
  • Moderna Inc.
  • Johnson & Johnson
  • Abbott Laboratories
  • Becton Dickinson（BD）
  • Bio-Rad Laboratories
  • Amgen Inc.
  • Regeneron Pharmaceuticals, Inc.
  • Biogen Inc.
  • Vertex Pharmaceuticals Inc.
  • Bristol-Myers Squibb Company
  • Novo Nordisk A/S
  • Gilead Sciences Inc.
  • Novartis AG

第20章：競爭基準化分析

第21章 競爭格局分析

第22章 重大併購

  • Bio-Rad Expands Global Digital PCR Capabilities Through Strategic Acquisition of Stilla Technologies
  • STEMCELL Technologies Acquired Cellular Highways Ltd
  • Thermo Fisher Expands Biomanufacturing Edge With Solventum Acquisition
  • Yuhan Corporation Acquires Progen To Advance Multi-Target Antibody Drug Development
  • Ginkgo Bioworks Strengthens Bioengineering Leadership With Fgen AG Acquisition

第23章 生物工程技術市場最新趨勢 生物工程技術市場

第24章：機遇與策略

  • 2029年生物工程技術市場：提供新機會的國家
  • 2029年生物工程技術市場：新興細分市場機會
  • 2029年生物工程技術市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第25章 生物工程技術市場：結論與建議

  • 結論
  • 建議
    • 產品
    • 地方
    • 價格
    • 晉升
    • 人們

第26章附錄

簡介目錄
Product Code: o&s1821

Bioengineering technology is the application of engineering principles and techniques to biological systems and living organisms for the development of innovative products, processes and solutions in healthcare, agriculture and industry. It integrates disciplines such as biotechnology, materials science, electronics and computational modeling to address challenges in medicine, genetics, environmental sustainability and bio-manufacturing. The primary purpose of bioengineering technology is to improve human health, enhance quality of life and promote sustainability.

The global bioengineering technology market reached a value of nearly $320,380.84 million in 2024, having grown at a compound annual growth rate (CAGR) of 13.45% since 2019. The market is expected to grow from $320,380.84 million in 2024 to $565,164.47 million in 2029 at a rate of 12.02%. The market is then expected to grow at a CAGR of 10.26% from 2029 and reach $920,838.80 million in 2034.

Increasing Focus On Cell Therapies

Increasing focus on cell therapies propelled the growth of the bioengineering technology market during the historic period. The rising focus on cell therapies has fueled the bioengineering technology market as these therapies demand advanced tools for cell culture, genetic engineering and bioprocessing. Growing investments in regenerative medicine and personalized treatments are further driving innovation and adoption of bioengineering solutions. For instance, in April 2024, according to the American Society of Gene & Cell Therapy, a US-based organization for gene and cell therapy, in quarter four (Q4), the number of gene therapies in Phase III clinical trials increased by 10%, marking the first quarterly growth of this kind since quarter three (Q3) 2022. Therefore, increasing focus on cell therapies propelled the growth of the bioengineering technology market.

Automated Tissue Dissociation System Enhances Cell Therapy And Research Efficiency

Major companies in the bioengineering technology market are developing high viability and cell yield to improve the efficiency of cell-based therapies and biomanufacturing. These innovations aim to lower production costs, enhance scalability and accelerate the development of advanced therapeutics. For instance, in June 2025, STEMCELL Technologies, a Canada-based biotechnology company, launches the STEMprep Tissue Dissociator System, a benchtop instrument that automates and standardizes tissue dissociation, converting solid tissues into high-quality single-cell suspensions. Designed to save time and improve consistency, STEMprep preserves cell integrity and functionality, supporting accurate isolation and analysis. Researchers can utilize validated protocols or customize workflows across diverse tissue types, enhancing efficiency, reproducibility and data reliability, ultimately accelerating research in fields such as cancer and immunology.

The global bioengineering technology market is fragmented, with large number of small players operating in the market. The top 10 competitors in the market made up 11.55% of the total market in 2024.

Bioengineering Technology Global Market Opportunities And Strategies To 2034 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global bioengineering technology market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for bioengineering technology? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The bioengineering technology market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider bioengineering technology market; and compares it with other markets.

The report covers the following chapters

  • Introduction And Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by product, by technology and by application.
  • Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Growth Analysis And Strategic Analysis Framework- Analysis on PESTEL, end use industries, market growth rate, global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
  • Regional And Country Analysis- Historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison by region and country.
  • Market Segmentation- Contains the market values (2019-2024) (2024-2029, 2034F) and analysis for each segment by product, by technology and by application in the market. Historic (2019-2024) and forecast (2024-2029) and (2029-2034) market values and growth and market share comparison by region market.
  • Regional Market Size And Growth- Regional market size (2024), historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Other Major And Innovative Companies- Details on the company profiles of other major and innovative companies in the market.
  • Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
  • Competitive Dashboard- Briefs on competitive dashboard of major players.
  • Key Mergers And Acquisitions- Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
  • Recent Developments- Information on recent developments in the market covered in the report.
  • Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations- This section includes recommendations for bioengineering technology providers in terms of product/service offerings geographic expansion, marketing strategies and target groups
  • Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

  • 1) By Product: Biomedical Engineering; Genetic Engineering; Tissue Engineering; Biomaterial; Biomechanical Engineering; Nano-Biotechnology; Other Products
  • 2) By Technology: Nanobiotechnology; Tissue Engineering And Regeneration; DNA Sequencing; Cell-Based Assays; Fermentation; Chromatography; PCR Technology; Other Technologies
  • 3) By Application: Health; Food And Agriculture; Natural Resources And Environment; Industrial Processing; Bioinformatics; Other Applications
  • Companies Mentioned: Thermo Fisher Scientific; Roche Holding AG; Pfizer Inc.; Illumina, Inc; Agilent Technologies
  • Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time-series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; bioengineering technology indicators comparison.
  • Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

  • 1.1 Bioengineering Technology - Market Attractiveness And Macro Economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

  • 6.1 General Market Definition
  • 6.2 Summary
  • 6.3 Bioengineering Technology Market Definition And Segmentations
  • 6.4 Market Segmentation By Product
    • 6.4.1 Biomedical Engineering
    • 6.4.2 Genetic Engineering
    • 6.4.3 Tissue Engineering
    • 6.4.4 Biomaterial
    • 6.4.5 Biomechanical Engineering
    • 6.4.6 Nano-biotechnology
    • 6.4.7 Other Products
  • 6.5 Market Segmentation By Technology
    • 6.5.1 Nanobiotechnology
    • 6.5.2 Tissue Engineering And Regeneration
    • 6.5.3 DNA Sequencing
    • 6.5.4 Cell-Based Assays
    • 6.5.5 Fermentation
    • 6.5.6 Chromatography
    • 6.5.7 PCR Technology
    • 6.5.8 Other Technologies
  • 6.6 Market Segmentation By Application
    • 6.6.1 Health
    • 6.6.2 Food And Agriculture
    • 6.6.3 Natural Resources And Environment
    • 6.6.4 Industrial Processing Segment
    • 6.6.5 Bioinformatics Segment
    • 6.6.6 Other Applications Segment

7 Major Market Trends

  • 7.1 Automated Tissue Dissociation System Enhances Cell Therapy And Research Efficiency
  • 7.2 Next-Generation Rice Crops Deliver Efficiency And Resilience
  • 7.3 Simulation-Based Tool Gains Ground In Medical Device Regulation
  • 7.4 Advanced Sustainable PTMEG Designed For High-Performance Applications
  • 7.5 Cutting-Edge Prosthetic Technology Balances Affordability And Performance
  • 7.6 Breakthrough Device Delivers Consistency In Biological Nanoparticle Analysis
  • 7.7 AI-Powered Omics Integration Sets New Benchmark In Biomedical Innovation
  • 7.8 AI-Driven RNA Sequencing And Analysis Revolutionizes Precision Medicine Research
  • 7.9 Next-Generation Genomic Profiling Transforms Precision Oncology With Liquid Biopsy Innovation
  • 7.10 Ultra-Fast NGS Technology Revolutionizes Somatic Cancer Analysis
  • 7.11 Next-Gen Platforms Boost Preclinical Drug Testing with Optical and Electrical Tissue Analysis

8 Bioengineering Technology Growth Analysis And Strategic Analysis Framework

  • 8.1 Global Bioengineering Technology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors)
    • 8.1.1 Political
    • 8.1.2 Economic
    • 8.1.3 Social
    • 8.1.4 Technological
    • 8.1.5 Environmental
    • 8.1.6 Legal
  • 8.2 Analysis Of End User (B2B)
    • 8.2.1 Hospitals
    • 8.2.2 Research And Academic Institutes
    • 8.2.3 Pharmaceutical And Biotechnology Companies
    • 8.2.4 Diagnostic Laboratories
    • 8.2.5 Medical Device Manufacturers
    • 8.2.6 Other Endusers (Contract Research Organizations (CROs), Government and Regulatory Agencies, Agriculture and Food Processing Companies)
  • 8.3 Bioengineering Technology Market Growth Rate Analysis
  • 8.4 Global Historic Market Growth, 2019 - 2024, Value ($ Million)
    • 8.4.1 Market Drivers 2019 - 2024
    • 8.4.2 Market Restraints 2019- 2024
  • 8.5 Global Forecast Market Growth, 2024 - 2029, 2034F Value ($ Million)
  • 8.6 Forecast Growth Contributors/Factors
    • 8.6.1 Quantitative Growth Contributors
    • 8.6.2 Drivers
    • 8.6.3 Restraints
  • 8.7 Bioengineering Technology Total Addressable Market (TAM)

9 Bioengineering Technology Market Segmentation

  • 9.1 Global Bioengineering Technology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.2 Global Bioengineering Technology Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.3 Global Bioengineering Technology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.4 Global Bioengineering Technology Market, Sub-Segmentation Of Biomedical Engineering, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.5 Global Bioengineering Technology Market, Sub-Segmentation Of Genetic Engineering, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.6 Global Bioengineering Technology Market, Sub-Segmentation Of Tissue Engineering, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.7 Global Bioengineering Technology Market, Sub-Segmentation Of Biomaterial, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.8 Global Bioengineering Technology Market, Sub-Segmentation Of Biomechanical Engineering, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.9 Global Bioengineering Technology Market, Sub-Segmentation Of Nano-Biotechnology, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.10 Global Bioengineering Technology Market, Sub-Segmentation Of Other Products, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

10 Bioengineering Technology Market, Regional and Country Analysis

  • 10.1 Bioengineering Technology Market, By Region, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 10.2 Bioengineering Technology Market, By Country, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

11 Asia-Pacific Market

  • 11.1 Summary
  • 11.2 Market Overview
    • 11.2.1 Region Information
    • 11.2.2 Market Information
    • 11.2.3 Background Information
    • 11.2.4 Government Initiatives
    • 11.2.5 Regulations
    • 11.2.6 Regulatory Bodies
    • 11.2.7 Major Associations
    • 11.2.8 Taxes Levied
    • 11.2.9 Corporate Tax Structure
    • 11.2.10 Investments
    • 11.2.11 Major Companies
  • 11.3 Asia-Pacific Bioengineering Technology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.4 Asia-Pacific Bioengineering Technology Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.5 Asia-Pacific Bioengineering Technology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.6 China Market
  • 11.7 Summary
  • 11.8 Market Overview
    • 11.8.1 Country Information
    • 11.8.2 Market Information
    • 11.8.3 Background Information
    • 11.8.4 Government Initiatives
    • 11.8.5 Regulations
    • 11.8.6 Regulatory Bodies
    • 11.8.7 Major Associations
    • 11.8.8 Taxes Levied
    • 11.8.9 Corporate Tax Structure
    • 11.8.10 Investments
    • 11.8.11 Major Companies
  • 11.9 China Bioengineering Technology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.10 China Bioengineering Technology Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.11 China Bioengineering Technology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.12 India Market
  • 11.13 India Bioengineering Technology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.14 India Bioengineering Technology Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.15 India Bioengineering Technology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.16 Japan Market
  • 11.17 Summary
  • 11.18 Market Overview
    • 11.18.1 Country Information
    • 11.18.2 Market Information
    • 11.18.3 Background Information
    • 11.18.4 Government Initiatives
    • 11.18.5 Regulations
    • 11.18.6 Regulatory Bodies
    • 11.18.7 Major Associations
    • 11.18.8 Taxes Levied
    • 11.18.9 Corporate Tax Structure
    • 11.18.10 Investments
    • 11.18.11 Major Companies
  • 11.19 Japan Bioengineering Technology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.20 Japan Bioengineering Technology Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.21 Japan Bioengineering Technology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.22 Australia Market
  • 11.23 Australia Bioengineering Technology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.24 Australia Bioengineering Technology Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.25 Australia Bioengineering Technology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.26 Indonesia Market
  • 11.27 Indonesia Bioengineering Technology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.28 Indonesia Bioengineering Technology Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.29 Indonesia Bioengineering Technology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.30 South Korea Market
  • 11.31 Summary
  • 11.32 Market Overview
    • 11.32.1 Country Information
    • 11.32.2 Market Information
    • 11.32.3 Background Information
    • 11.32.4 Government Initiatives
    • 11.32.5 Regulations
    • 11.32.6 Regulatory Bodies
    • 11.32.7 Major Associations
    • 11.32.8 Taxes Levied
    • 11.32.9 Corporate Tax Structure
    • 11.32.10 Investments
    • 11.32.11 Major Companies
  • 11.33 South Korea Bioengineering Technology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.34 South Korea Bioengineering Technology Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.35 South Korea Bioengineering Technology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

12 Western Europe Market

  • 12.1 Summary
  • 12.2 Market Overview
    • 12.2.1 Region Information
    • 12.2.2 Market Information
    • 12.2.3 Background Information
    • 12.2.4 Government Initiatives
    • 12.2.5 Regulations
    • 12.2.6 Regulatory Bodies
    • 12.2.7 Major Associations
    • 12.2.8 Taxes Levied
    • 12.2.9 Corporate tax structure
    • 12.2.10 Investments
    • 12.2.11 Major Companies
  • 12.3 Western Europe Bioengineering Technology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.4 Western Europe Bioengineering Technology Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.5 Western Europe Bioengineering Technology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.6 Western Europe Bioengineering Technology Market: Country Analysis
  • 12.7 UK Market
  • 12.8 UK Bioengineering Technology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.9 UK Bioengineering Technology Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.10 UK Bioengineering Technology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.11 Germany Market
  • 12.12 Germany Bioengineering Technology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.13 Germany Bioengineering Technology Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.14 Germany Bioengineering Technology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.15 France Market
  • 12.16 France Bioengineering Technology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.17 France Bioengineering Technology Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.18 France Bioengineering Technology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.19 Italy Market
  • 12.20 Italy Bioengineering Technology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.21 Italy Bioengineering Technology Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.22 Italy Bioengineering Technology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.23 Spain Market
  • 12.24 Spain Bioengineering Technology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.25 Spain Bioengineering Technology Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.26 Spain Bioengineering Technology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

13 Eastern Europe Market

  • 13.1 Summary
  • 13.2 Market Overview
    • 13.2.1 Region Information
    • 13.2.2 Market Information
    • 13.2.3 Background Information
    • 13.2.4 Government Initiatives
    • 13.2.5 Regulations
    • 13.2.6 Regulatory Bodies
    • 13.2.7 Major Associations
    • 13.2.8 Taxes Levied
    • 13.2.9 Corporate Tax Structure
    • 13.2.10 Investments
    • 13.2.11 Major companies
  • 13.3 Eastern Europe Bioengineering Technology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.4 Eastern Europe Bioengineering Technology Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.5 Eastern Europe Bioengineering Technology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.6 Eastern Europe Bioengineering Technology Market: Country Analysis
  • 13.7 Russia Market
  • 13.8 Russia Bioengineering Technology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.9 Russia Bioengineering Technology Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.10 Russia Bioengineering Technology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

14 North America Market

  • 14.1 Summary
  • 14.2 Market Overview
    • 14.2.1 Region Information
    • 14.2.2 Market Information
    • 14.2.3 Background Information
    • 14.2.4 Government Initiatives
    • 14.2.5 Regulations
    • 14.2.6 Regulatory Bodies
    • 14.2.7 Major Associations
    • 14.2.8 Taxes Levied
    • 14.2.9 Corporate Tax Structure
    • 14.2.10 Investments
    • 14.2.11 Major Companies
  • 14.3 North America Bioengineering Technology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.4 North America Bioengineering Technology Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.5 North America Bioengineering Technology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.6 North America Bioengineering Technology Market: Country Analysis
  • 14.7 USA Market
  • 14.8 Summary
  • 14.9 Market Overview
    • 14.9.1 Country Information
    • 14.9.2 Market Information
    • 14.9.3 Background Information
    • 14.9.4 Government Initiatives
    • 14.9.5 Regulations
    • 14.9.6 Regulatory Bodies
    • 14.9.7 Major Associations
    • 14.9.8 Taxes Levied
    • 14.9.9 Corporate Tax Structure
    • 14.9.10 Investments
    • 14.9.11 Major Companies
  • 14.10 USA Bioengineering Technology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.11 USA Bioengineering Technology Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.12 USA Bioengineering Technology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.13 Canada Market
  • 14.14 Summary
  • 14.15 Market Overview
    • 14.15.1 Country Information
    • 14.15.2 Market Information
    • 14.15.3 Background Information
    • 14.15.4 Government Initiatives
    • 14.15.5 Regulations
    • 14.15.6 Regulatory Bodies
    • 14.15.7 Major Associations
    • 14.15.8 Taxes Levied
    • 14.15.9 Corporate Tax Structure
    • 14.15.10 Investments
    • 14.15.11 Major Companies
  • 14.16 Canada Bioengineering Technology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.17 Canada Bioengineering Technology Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.18 Canada Bioengineering Technology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

15 South America Market

  • 15.1 Summary
  • 15.2 Market Overview
    • 15.2.1 Region Information
    • 15.2.2 Market Information
    • 15.2.3 Background Information
    • 15.2.4 Government Initiatives
    • 15.2.5 Regulations
    • 15.2.6 Regulatory Bodies
    • 15.2.7 Major Associations
    • 15.2.8 Taxes Levied
    • 15.2.9 Corporate Tax Structure
    • 15.2.10 Investments
    • 15.2.11 Major Companies
  • 15.3 South America Bioengineering Technology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.4 South America Bioengineering Technology Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.5 South America Bioengineering Technology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.6 South America Bioengineering Technology Market: Country Analysis
  • 15.7 Brazil Market
  • 15.8 Brazil Bioengineering Technology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.9 Brazil Bioengineering Technology Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.10 Brazil Bioengineering Technology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

16 Middle East Market

  • 16.1 Summary
  • 16.2 Market Overview
    • 16.2.1 Region Information
    • 16.2.2 Market Information
    • 16.2.3 Background Information
    • 16.2.4 Government Initiatives
    • 16.2.5 Regulations
    • 16.2.6 Regulatory Bodies
    • 16.2.7 Major Associations
    • 16.2.8 Taxes Levied
    • 16.2.9 Corporate Tax Structure
    • 16.2.10 Investments
    • 16.2.11 Major Companies
  • 16.3 Middle East Bioengineering Technology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 16.4 Middle East Bioengineering Technology Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 16.5 Middle East Bioengineering Technology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

17 Africa Market

  • 17.1 Summary
  • 17.2 Market Overview
    • 17.2.1 Region Information
    • 17.2.2 Market Information
    • 17.2.3 Background Information
    • 17.2.4 Government Initiatives
    • 17.2.5 Regulations
    • 17.2.6 Regulatory Bodies
    • 17.2.7 Major Associations
    • 17.2.8 Taxes Levied
    • 17.2.9 Corporate Tax Structure
    • 17.2.10 Investments
    • 17.2.11 Major Companies
  • 17.3 Africa Bioengineering Technology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 17.4 Africa Bioengineering Technology Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 17.5 Africa Bioengineering Technology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

18 Competitive Landscape And Company Profiles

  • 18.1 Company Profiles
  • 18.2 Thermo Fisher Scientific Inc
    • 18.2.1 Company Overview
    • 18.2.2 Products And Services
    • 18.2.3 Business Strategy
    • 18.2.4 Financial Overview
  • 18.3 Roche Holding AG
    • 18.3.1 Company Overview
    • 18.3.2 Products And Services
    • 18.3.3 Business Strategy
    • 18.3.4 Financial Overview
  • 18.4 Pfizer Inc
    • 18.4.1 Company Overview
    • 18.4.2 Products And Services
    • 18.4.3 Business Strategy
    • 18.4.4 Financial Overview
  • 18.5 Illumina Inc
    • 18.5.1 Company Overview
    • 18.5.2 Products And Services
    • 18.5.3 Business Strategy
    • 18.5.4 Financial Overview
  • 18.6 Agilent Technologies Inc
    • 18.6.1 Company Overview
    • 18.6.2 Products And Services
    • 18.6.3 Business Strategy
    • 18.6.4 Financial Overview

19 Other Major And Innovative Companies

  • 19.1 AstraZeneca plc
    • 19.1.1 Company Overview
    • 19.1.2 Products And Services
  • 19.2 Lonza Group Ltd.
    • 19.2.1 Company Overview
    • 19.2.2 Products And Services
  • 19.3 Moderna Inc.
    • 19.3.1 Company Overview
    • 19.3.2 Products And Services
  • 19.4 Johnson & Johnson
    • 19.4.1 Company Overview
    • 19.4.2 Products And Services
  • 19.5 Abbott Laboratories
    • 19.5.1 Company Overview
    • 19.5.2 Products And Services
  • 19.6 Becton Dickinson (BD)
    • 19.6.1 Company Overview
    • 19.6.2 Products And Services
  • 19.7 Bio-Rad Laboratories
    • 19.7.1 Company Overview
    • 19.7.2 Products And Services
  • 19.8 Amgen Inc.
    • 19.8.1 Company Overview
    • 19.8.2 Products And Services
  • 19.9 Regeneron Pharmaceuticals, Inc.
    • 19.9.1 Company Overview
    • 19.9.2 Products And Services
  • 19.10 Biogen Inc.
    • 19.10.1 Company Overview
    • 19.10.2 Products And Services
  • 19.11 Vertex Pharmaceuticals Inc.
    • 19.11.1 Company Overview
    • 19.11.2 Products And Services
  • 19.12 Bristol-Myers Squibb Company
    • 19.12.1 Company Overview
    • 19.12.2 Products And Services
  • 19.13 Novo Nordisk A/S
    • 19.13.1 Company Overview
    • 19.13.2 Products And Services
  • 19.14 Gilead Sciences Inc.
    • 19.14.1 Company Overview
    • 19.14.2 Products And Services
  • 19.15 Novartis AG
    • 19.15.1 Company Overview
    • 19.15.2 Products And Services

20 Competitive Benchmarking

21 Competitive Dashboard

22 Key Mergers And Acquisitions

  • 22.1 Bio-Rad Expands Global Digital PCR Capabilities Through Strategic Acquisition of Stilla Technologies
  • 22.2 STEMCELL Technologies Acquired Cellular Highways Ltd
  • 22.3 Thermo Fisher Expands Biomanufacturing Edge With Solventum Acquisition
  • 22.4 Yuhan Corporation Acquires Progen To Advance Multi-Target Antibody Drug Development
  • 22.5 Ginkgo Bioworks Strengthens Bioengineering Leadership With Fgen AG Acquisition

23 Recent Developments In The Bioengineering Technology Market

  • 23.1 AI Platform Revolutionizes Access to Advanced Drug Discovery for Biotech Firms
  • 23.2 High-Yield AAV Platform Boosts Scalable Gene Therapy Manufacturing

24 Opportunities And Strategies

  • 24.1 Bioengineering Technology Market In 2029 - Countries Offering Most New Opportunities
  • 24.2 Bioengineering Technology Market In 2029 - Segments Offering Most New Opportunities
  • 24.3 Bioengineering Technology Market In 2029 - Growth Strategies
    • 24.3.1 Market Trend Based Strategies
    • 24.3.2 Competitor Strategies

25 Bioengineering Technology Market, Conclusions And Recommendations

  • 25.1 Conclusions
  • 25.2 Recommendations
    • 25.2.1 Product
    • 25.2.2 Place
    • 25.2.3 Price
    • 25.2.4 Promotion
    • 25.2.5 People

26 Appendix

  • 26.1 Geographies Covered
  • 26.2 Market Data Sources
  • 26.3 Research Methodology
  • 26.4 Currencies
  • 26.5 The Business Research Company
  • 26.6 Copyright and Disclaimer